Clinical Trials Browser

OTHER_GOV × Neoplasms × Nivolumab × Clear all

NCT02999295 2019-08-21

A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer

Phase 1/2 Completed

Gastrointestinal

Neoplasms, Stomach Neoplasms